Liposomal Doxorubicin Plus Gemcitabine Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma

NCT02527772 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped It doesn't meet the requirements of randomized trials

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: Liposomal Doxorubicin+Gemcitabine
DRUG: FOLFOX4

Sponsor

Guangxi Medical University